Company / FCF Margin
BIOCRYST PHARMACEUTICALS INC FCF Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-164.7%
FY2017
5-year range
-
FY2016-FY2017
Trend
+26.1%
vs FY2016
Sector context
#97 of 133
Health Care
What the data says
At -164.7%, BIOCRYST PHARMACEUTICALS INC's fcf margin ranks #97 of 133 in the Health Care sector.
Based on SEC 10-K filings.
-164.7% in FY2017.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#97 of 133 in Health CareTop 73% of 133This company -164.7% Sector average -632.8%
▼
+74.0% above sector average
Key checks
Key Insights
- In FY2017, fcf margin increased 26.1% year-over-year.
- Currently 468.2pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -164.7% | +26.1% |
| FY2016 | -222.8% | -489.6% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026